ArticleAlzheimer's & dementia (New York, N. Y.)2022

In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic model.

Roxana Aldea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.